Shishi Pharmaceutical Group (02005): Obtained drug production registration approval for perindopril amlodipine tablets (III) (perindopril arginine 10mg, amlodipine benzenesulfonate 5mg)

Zhitong Finance App News, Shijiyao Group (02005) issued an announcement. The Group has obtained approval from the China National Drug Administration for the production of perindopriamlodipine tablets (III) (arginine perindopril 10mg, amlodipine benzenesulfonate 5mg), which are Class 4 chemicals and are deemed to have passed the consistency evaluation.

Perindopril amlodipine tablets (III) are compound preparations, mainly used for monotherapy in adult patients who cannot adequately control high blood pressure, or as an alternative therapy for essential hypertension whose condition is controlled under combination treatment with perindopril and amlodipine at the same dose level.